LPA and hyperlipoproteinemia: In contrast, in individuals with Type-IV hyperlipoproteinemia, where patients consistently show an impaired Glc tolerance or T2DM, Lp(a) appeared to be a “negative risk factor,” i.e., MI patients had lower Lp(a) levels than controls (Figure 11).